The Journal of Bone and Joint Surgery (American). 2006;88:1231-1237.
doi:10.2106/JBJS.E.00004
© 2006 The Journal of Bone and Joint Surgery, Inc.
Antibiotic Susceptibility of Bacteria Infecting Total Joint Arthroplasty Sites
Eric Fulkerson, MD1,
Craig J. Della Valle, MD2,
Brent Wise, MD1,
Michael Walsh, PhD1,
Charles Preston, MD1 and
Paul E. Di Cesare, MD1
1 Musculoskeletal Research Center, Department of Orthopaedic Surgery, New York
University Hospital for Joint Diseases, 301 East 17th Street, New York, NY
10003. E-mail address for P.E. Di Cesare:
pedicesare{at}aol.com
2 Rush University Medical Center, Midwest Orthopaedics, 1725 West Harrison
Street, Suite 1063, Chicago, IL 60612
Investigation performed at the Musculoskeletal Research Center, New
York University Hospital for Joint Diseases, New York, NY, and Rush University
Medical Center, Midwest Orthopaedics, Chicago, Illinois
The authors did not receive grants or outside funding in support of their
research for or preparation of this manuscript. They did not receive payments
or other benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, educational
institution, or other charitable or nonprofit organization with which the
authors are affiliated or associated.
Background: Currently, there is no consensus regarding the
principles of empiric antibiotic treatment of suspected periprosthetic
infection following total knee and hip arthroplasties. This study was
undertaken to attempt to establish such principles.
Methods: We performed a retrospective analysis of 146 patients who
had had a total of 194 positive cultures of specimens obtained at the time of
a reoperation following a total knee or total hip arthroplasty at one of two
institutions. Patient demographic data, comorbid conditions, bacterial
species, the antibiotic sensitivity profile, and the postoperative day on
which the culture tested positive were recorded.
Results: Specimens from 110 hips and eighty-four knees were positive
on culture. Seventy percent of the infections were classified as chronic; 17%,
as acute postoperative; and 13%, as acute hematogenous. The mean time between
the operation and the positive culture results was three days. Gram-positive
organisms caused the majority of the infections. In the series as a whole, 88%
of the bacteria were sensitive to gentamicin; 96%, to vancomycin; and 61%, to
cefazolin. The most antibiotic-resistant bacterial strains were from patients
for whom prior antibiotic treatment had failed. Acute postoperative infections
had a greater resistance profile than did chronic or hematogenous infections.
Bacteria isolated from patients with a hematogenous infection had a high
sensitivity to both cefazolin and gentamicin.
Conclusions: Empiric antibiotic treatment for suspected
periprosthetic infection should be guided by the class of the infection and
the findings of Gram staining. We believe that, until the final culture
results are available, acute hematogenous infections should initially be
treated by a combination of cefazolin and gentamicin therapy. All chronic and
acute postoperative infections with Gram-positive bacteria and all cases in
which a Gram stain fails to identify bacteria should be managed with
vancomycin. Infections with Gram-negative bacteria should be managed with a
third or fourth-generation cephalosporin. Infections with mixed Gram-positive
and Gram-negative bacteria should be managed with a combination of vancomycin
and a third or fourth-generation cephalosporin. Furthermore, we believe that
if culture results and other confirmatory tests are not positive by the fourth
postoperative day, termination of empiric antibiotic therapy should be
considered.
Level of Evidence: Diagnostic Level IV. See Instructions
to Authors for a complete description of levels of evidence.

CiteULike Connotea Del.icio.us Facebook Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Meehan, A. A. Jamali, and H. Nguyen
Prophylactic Antibiotics in Hip and Knee Arthroplasty
J. Bone Joint Surg. Am.,
October 1, 2009;
91(10):
2480 - 2490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Lonner and C. A. Deirmengian
What's New in Adult Reconstructive Knee Surgery
J. Bone Joint Surg. Am.,
December 1, 2007;
89(12):
2828 - 2837.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Huo, N. F. Gilbert, and J. Parvizi
What's New in Total Hip Arthroplasty
J. Bone Joint Surg. Am.,
August 1, 2007;
89(8):
1874 - 1885.
[Full Text]
[PDF]
|
 |
|
|